Latest filings (excl ownership)
10-K/A
2023 FY
Annual report (amended)
29 Apr 24
8-K
Other Events
5 Apr 24
S-8
Registration of securities for employees
29 Mar 24
S-3
Shelf registration
29 Mar 24
10-K
2023 FY
Annual report
29 Mar 24
8-K
Results of Operations and Financial Condition
29 Mar 24
D
$6.00 mm in options / securities to be acquired, sold $6.00 mm, 1 investor
28 Mar 24
8-K
Entry into a Material Definitive Agreement
18 Mar 24
8-K
Departure of Directors or Certain Officers
2 Feb 24
8-K
Other Events
17 Jan 24
8-K
Other Events
16 Jan 24
8-K
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
9 Jan 24
D
$7.05 mm in equity, sold $7.05 mm, 1 investor
5 Jan 24
8-K
Entry into a Material Definitive Agreement
22 Dec 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Results of Operations and Financial Condition
9 Nov 23
8-K
Other Events
3 Nov 23
8-K
Departure of Directors or Certain Officers
20 Oct 23
8-K
Departure of Directors or Certain Officers
12 Oct 23
8-K
Other Events
27 Sep 23
8-K
Other Events
7 Sep 23
8-K
Departure of Directors or Certain Officers
30 Aug 23
S-8
Registration of securities for employees
21 Aug 23
8-K/A
Elicio Therapeutics, Inc. Financial Statements
11 Aug 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
8-K
Elicio Therapeutics Reports Second Quarter 2023 Financial Results and Provides
11 Aug 23
8-K
Other Events
5 Jun 23
8-K
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
2 Jun 23
425
Business combination disclosure
30 May 23
8-K
Other Events
30 May 23
425
Business combination disclosure
23 May 23
8-K
Other Events
23 May 23
10-Q
2023 Q1
Quarterly report
10 May 23
8-K
Other Events
1 May 23
EFFECT
Notice of effectiveness
1 May 23
10-K/A
2022 FY
Annual report (amended)
28 Apr 23
424B3
Prospectus supplement
28 Apr 23
SEC STAFF
SEC staff action: Order
28 Apr 23
8-K
Other Events
27 Apr 23
Latest ownership filings
SC 13D/A
Clal Biotechnology Industries Ltd.
10 Apr 24
SC 13D/A
Clal Biotechnology Industries Ltd.
20 Mar 24
SC 13D/A
GKCC, LLC
20 Mar 24
4
Yekaterina Chudnovsky
20 Mar 24
4
Brian Piekos
5 Feb 24
4
Robert Connelly
5 Feb 24
4
Christopher Haqq
5 Feb 24
4
Peter DeMuth
5 Feb 24
4
Allen Nissenson
29 Dec 23
4
Yekaterina Chudnovsky
29 Dec 23
4
KAREN J WILSON
29 Dec 23
4
JULIAN ADAMS
29 Dec 23
4
Jay Venkatesan
29 Dec 23
4
Carol Gail Ashe
29 Dec 23
4
ROBERT R RUFFOLO
29 Dec 23
SC 13D/A
Clal Biotechnology Industries Ltd.
27 Dec 23
4
Yekaterina Chudnovsky
26 Dec 23
SC 13D/A
GKCC, LLC
26 Dec 23
SC 13D/A
Clal Biotechnology Industries Ltd.
30 Aug 23
SC 13G/A
Vifor (International) Ltd
7 Jul 23
SC 13D/A
Elicio Therapeutics / Elicio Therapeutics ownership change
14 Jun 23
SC 13D
GKCC, LLC
14 Jun 23
3
Yekaterina Chudnovsky
12 Jun 23
3
Christopher Haqq
12 Jun 23
SC 13D
Clal Biotechnology Industries Ltd.
12 Jun 23
3
Peter DeMuth
7 Jun 23
3
Assaf Segal
7 Jun 23
3
ROBERT R RUFFOLO
7 Jun 23
3
Annette Matthies
7 Jun 23
3
JULIAN ADAMS
7 Jun 23
3
Robert Connelly
7 Jun 23
3
Carol Gail Ashe
7 Jun 23
4
Brian Piekos
5 Jun 23
3
Brian Piekos
5 Jun 23
SC 13G/A
Goldberg Itzhak
14 Feb 23
SC 13G/A
EISA-ABC LLC
14 Feb 23
SC 13G/A
SATTERFIELD THOMAS A JR
10 Feb 23
4
Itzhak Goldberg
11 Jul 22
4
VICTOR F GANZI
13 Jun 22
4
Allen Nissenson
13 Jun 22